| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.004 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |